Stheno Corporation was founded on June 24th of 2003 by Phillip Gibbs and William Edens to enhance the quality and safety of consumer chemical products with a specific focus on the pharmaceutical industry. Stheno is a privately owned C type corporation operating in Atlanta, Georgia. The technology at Stheno's heart is a patent pending chemical detection system termed Magneto-Optical Enantiomeric Detection or MOPED™. MOPED™ is a platform technology that will allow sensitive detection of chiral molecules in solution.

Stheno has assembled a top-notch team of engineers, scientists, and programmers with expertise ranging from biochemistry to optical physics. This team is responsible for the groundbreaking innovations that make Stheno’s core technology the powerful analytical platform that it is today.

Stheno Corporation has assembled a top-notch team of engineers, scientists and programmers with expertise ranging from biochemistry to optical physics. This team is responsible for the groundbreaking innovations that make MOPED technology the powerful analytical platform that it is today.